• 1_Accelero_FirePlex_miRNAv1.jpg
  • 2_Accelero_FirePlex_miRNAv2.jpg
  • 3_Accelero_FirePlex_miRNAv3.jpg
  • 4_Accelero_FirePlex_immunoV2.jpg
  • 5_Accelero_FirePlex_immunoV1.jpg

The Accelero Bioanalytics test facility in Berlin Adlershof (Germany) has been approved by the competent authority to work in compliance with the principles of Good Laboratory Practice (GLP), as defined in the respective OECD guidelines. The test facility is GLP certified for the following OECD categories:

Category 1 = testing of physical-chemical properties, and content determinations

Category 8 = analytical and clinical testing on biological material


To download the press release (separate versions in german and english are available),
please click here.

To download the 2016 GLP certificate from the competent authority,
please click here.


Please consult the OECD website for a complete list on GLP relevant guidelines.

Accelero has been guided by Dr. Knoell Consult GmbH to provide a living and flexible GLP quality assurance program for Accelero´s drug development customers.

Accelero GLP Organigram 2016

Accelero´s GLP external archive is provided by Rhenus Office Systems GmbH, a certified GLP test site located in Großbeeren near Berlin. According to Appendix 1 to §19a Section 1 of the German Chemical Act (Chemikaliengesetz, ChemG) all GLP relevant documents must be archived for 15 years. The contract archiving service is regularly inspected by the Accelero Quality Assurance Unit as suggested in OECD Guideline No. 15.

Accelero´s founder is a member of the German Society for Good Research Practice (Deutsche Gesellschaft für Gute Forschungspraxis, DGGF eV).


Last update of this site: 04-FEB-2016 by Christian Lange.